High expression of CD 44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine-Reference-Cited by-同舟云学术

High expression of CD 44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine

Published:2018-08-16 Issue:9 Volume:109 Page:2801-2810
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Wada Fumitaka¹²,Koga Hironori¹²^ORCID,Akiba Jun³,Niizeki Takashi¹,Iwamoto Hideki¹²,Ikezono Yu¹²,Nakamura Toru¹²,Abe Mitsuhiko¹²,Masuda Atsutaka¹²,Sakaue Takahiko¹²,Tanaka Toshimitsu¹²,Kakuma Tatsuyuki⁴,Yano Hirohisa³,Torimura Takuji¹²

Affiliation:

1. Division of Gastroenterology Department of Medicine Kurume University School of Medicine Kurume Japan

2. Liver Cancer Research Division Research Center for Innovative Cancer Therapy Kurume University Kurume Japan

3. Department of Pathology Kurume University School of Medicine Kurume Japan

4. Biostatistics Center Kurume University Kurume Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13728

Reference29 articles.

1. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012

2. Hepatocellular carcinoma

3. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

4. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

5. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma;Pang RW;Curr Cancer Drug Targets,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity;Biochemical Journal;2023-12-18

2. The amino acid transporter SLC7A11 expression in breast cancer;Cancer Biology & Therapy;2023-12-10

3. Targeting ferroptosis opens new avenues for the development of novel therapeutics;Signal Transduction and Targeted Therapy;2023-09-21

4. Glutathione and glutathione disulfide – their biomedical and pharmaceutical applications;Medicinal Chemistry Research;2023-07-28

5. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma;Cell Death & Disease;2023-07-17